Akebia Therapeutics reported $19.71M in Trade Creditors for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US USD 12.75M 2.74M
Agios Pharmaceuticals AGIO:US USD 18.62M 8.2M
Alnylam Pharmaceuticals ALNY:US USD 98.09M 57.52M
Ardelyx ARDX:US USD 10.86M 7.75M
Astellas Pharma 4503:JP JPY 134.24B 12.3B
Avrobio Inc AVRO:US USD 384K 1.43M
Bayer BAYN:GR EUR 7.55B 996M
Exelixis EXEL:US USD 32.67M 2.09M
Intercept Pharmaceuticals ICPT:US USD 14.23M 7.07M
Ironwood Pharmaceuticals IRWD:US USD 483K 312K
Lexicon Pharmaceuticals LXRX:US USD 10.4M 968K
Moderna Inc MRNA:US USD 487M 157M
Nektar Therapeutics NKTR:US USD 12.98M 7.65M
Opko Health OPK:US USD 67M 17.25M
Prothena PRTA:US USD 9.27M 518K
Ptc Therapeutics PTCT:US USD 27.27M 6.41M
Sarepta Therapeutics SRPT:US USD 95.88M 22.59M
Seattle Genetics SGEN:US USD 207.85M 63.35M
Vanda Pharmaceuticals VNDA:US USD 4.98M 606K